Fed. Circ. Upholds Toenail Drug IP Nix After Bass Challenge
Anacor Pharmaceuticals Inc. on Monday lost its bid at the Federal Circuit to revive part of a patent covering toenail fungus treatment Kerydin, which the Patent Trial and Appeal Board invalidated...To view the full article, register now.
Already a subscriber? Click here to view full article